Nazione: Portogallo
Lingua: inglese
Fonte: HMA (Heads of Medicines Agencies)
milbemycin A<3>-oxim 16 mg, praziquantel 40 mg
Norvartis Animal Health UK Ltd
QP54AB51
Tablet
Milbemycin, combinations
Cats
2011-04-17
MILBEMAX Cats Final SPC RENEWAL July 2007 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MILBEMAX ® Film-coated tablets for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substances: Milbemycin oxime Praziquantel 16 mg 40 mg Excipients: Titanium dioxide (E171) Iron oxide (E172) 0.312 mg 0.312 mg Excipients QSP one divisable tablet of 130 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Film-coated tablet Oblong shaped, dark red, with a score on one side. One side bears the imprint “KK”, the other side “NA”. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats 4.2 INDICATIONS FOR USE In cats: treatment of mixed infections by immature and adult cestodes AND nematodes of the following species : MILBEMAX Cats Final SPC RENEWAL July 2007 - Cestodes: _Dipylidium caninum _ _Taenia spp. _ _Echinococcus multilocularis _ - Nematodes: _Ancylostoma tubaeforme _ _Toxocara cati _ _ _ Prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is indicated 4.3 CONTRA-INDICATIONS Do not use in cats weighing less than 2 kg 4.4 SPECIAL WARNINGS None 4.5 SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS SPECIAL PRECAUTIONS FOR USE IN ANIMALS As per good veterinary practice, animals should be weighed to ensure accurate dosing Echinococcosis represents a hazard for humans. In case of Echinococcosis, specific guidelines on the treatment and follow up and on the safeguard of persons have to be followe Leggi il documento completo